bisbenzimidazole and paclitaxel

bisbenzimidazole has been researched along with paclitaxel in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, MS; Chu, NY; Ikejima, T; Jiang, CG; Liu, C; Wang, QH; Wang, XJ; Wang, XY	1
Mimata, H; Nomura, T; Nomura, Y; Yamasaki, M	1

Other Studies

2 other study(ies) available for bisbenzimidazole and paclitaxel

Article	Year
Newly synthesized bis-benzimidazole derivatives exerting anti-tumor activity through induction of apoptosis and autophagy. Bioorganic & medicinal chemistry letters, 2012, Oct-01, Volume: 22, Issue:19 Topics: Antineoplastic Agents; Apoptosis; Autophagy; Bisbenzimidazole; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HeLa Cells; HL-60 Cells; Humans; Leukocytes, Mononuclear; Molecular Structure; Structure-Activity Relationship; U937 Cells	2012
Expression of the inhibitors of apoptosis proteins in cisplatin-resistant prostate cancer cells. Oncology reports, 2005, Volume: 14, Issue:4 Topics: Apoptosis; Baculoviral IAP Repeat-Containing 3 Protein; Bisbenzimidazole; Cell Line, Tumor; Cell Proliferation; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Fluorouracil; Humans; Immunoblotting; Inhibitor of Apoptosis Proteins; Male; Microtubule-Associated Proteins; Neoplasm Proteins; Neuronal Apoptosis-Inhibitory Protein; Paclitaxel; Phenotype; Prostatic Neoplasms; Survivin; Taxoids; Tetrazolium Salts; Time Factors; Ubiquitin-Protein Ligases; X-Linked Inhibitor of Apoptosis Protein	2005

Article

Year

Newly synthesized bis-benzimidazole derivatives exerting anti-tumor activity through induction of apoptosis and autophagy.

Bioorganic & medicinal chemistry letters, 2012, Oct-01, Volume: 22, Issue:19

Topics: Antineoplastic Agents; Apoptosis; Autophagy; Bisbenzimidazole; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HeLa Cells; HL-60 Cells; Humans; Leukocytes, Mononuclear; Molecular Structure; Structure-Activity Relationship; U937 Cells

2012

Expression of the inhibitors of apoptosis proteins in cisplatin-resistant prostate cancer cells.

Oncology reports, 2005, Volume: 14, Issue:4

Topics: Apoptosis; Baculoviral IAP Repeat-Containing 3 Protein; Bisbenzimidazole; Cell Line, Tumor; Cell Proliferation; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Fluorouracil; Humans; Immunoblotting; Inhibitor of Apoptosis Proteins; Male; Microtubule-Associated Proteins; Neoplasm Proteins; Neuronal Apoptosis-Inhibitory Protein; Paclitaxel; Phenotype; Prostatic Neoplasms; Survivin; Taxoids; Tetrazolium Salts; Time Factors; Ubiquitin-Protein Ligases; X-Linked Inhibitor of Apoptosis Protein

2005